Lightlake Therapeutics Inc - New York City, New York 10022

Lightlake Therapeutics Inc is categorized under in New York City, NY .

Business Name: Lightlake Therapeutics Inc
Contact Person: Roger Crystal
Address: 251 East 51st St Apartment 9c, New York City, New York 10022
Phone Number: (917) 273-3611
Annual Revenue (USD): $50.000 to $99.999
Founding Year: 2014
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 325412
Share This Business:
Related Businesses: Tonix Pharmaceuticals Inc - New York City, NY 10022
Krele LLC - New York City, NY 10022
Melinta Pharmaceuticals Inc - New York City, NY 10022
Aoi Pharma Inc - New York City, NY 10022
Niobe Ventures LLC - New York City, NY 10022
Ohr Pharmaceutical Inc - New York City, NY 10022
Stemline Therapeutics Inc - New York City, NY 10022
Bristol-Myers Squibb Company - New York City, NY 10022
Forest Laboratories Inc - New York City, NY 10022
Keryx Biopharmaceuticals Inc - New York City, NY 10022
Danube Pharmaceuticals Inc - New York City, NY 10022

The company Lightlake Therapeutics Inc provides BOTH services in the form of from its single location in New York. 1 to 4 employees work for Lightlake Therapeutics Inc, and the business now earns $50.000 to $99.999 per annum.

Lightlake Therapeutics Inc was launched in 2014 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 . To contact Lightlake Therapeutics Inc, please call Roger Crystal with the phone number (917) 273-3611 or visit its single location at 251 East 51st St Apartment 9c in New York City, New York 10022.

The location of the single location can also be found using the coordinates . Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.